×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RAPP – rapport therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RAPP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/22
11:42 am
rapp
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? [Yahoo! Finance]
Low
Report
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? [Yahoo! Finance]
12/19
08:44 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) was given a new $51.00 price target on by analysts at Wells Fargo & Company.
Medium
Report
Rapport Therapeutics (NASDAQ:RAPP) was given a new $51.00 price target on by analysts at Wells Fargo & Company.
12/19
07:19 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Medium
Report
Rapport Therapeutics (NASDAQ:RAPP) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
12/18
07:00 am
rapp
Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/9
07:21 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Rapport Therapeutics (NASDAQ:RAPP) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/8
08:07 am
rapp
Rapport Therapeutics (NASDAQ:RAPP) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $47.00 price target on the stock.
Low
Report
Rapport Therapeutics (NASDAQ:RAPP) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $47.00 price target on the stock.
12/7
02:21 am
rapp
Rapport Therapeutics (RAPP) Valuation Check After a 60% Year-to-Date Share Price Surge [Yahoo! Finance]
Low
Report
Rapport Therapeutics (RAPP) Valuation Check After a 60% Year-to-Date Share Price Surge [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2025
07:00 am
rapp
rapport therapeutics, inc.
BEAT
Report
-1.1%
rapport therapeutics, inc.
3/11/2025
07:00 am
rapp
rapport therapeutics, inc.
BEAT
Report
9.0%
rapport therapeutics, inc.
3/11/2025
07:00 am
rapp
rapport therapeutics, inc.
BEAT
Report
8.3%
rapport therapeutics, inc.
3/11/2025
07:00 am
rapp
rapport therapeutics, inc.
BEAT
Report
11.7%
rapport therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/18
04:11 pm
rapp
Form 4 Rapport Therapeutics, For: Dec 17 Filed by: Ceesay Abraham
Medium
Report
Form 4 Rapport Therapeutics, For: Dec 17 Filed by: Ceesay Abraham
12/17
04:28 pm
rapp
Form 144 Rapport Therapeutics, Filed by: Ceesay Abraham
Medium
Report
Form 144 Rapport Therapeutics, Filed by: Ceesay Abraham
12/17
04:25 pm
rapp
Form 144 Rapport Therapeutics, Filed by: Ceesay Abraham
Medium
Report
Form 144 Rapport Therapeutics, Filed by: Ceesay Abraham
12/16
05:07 pm
rapp
Form 4 Rapport Therapeutics, For: Dec 15 Filed by: Bredt David
Medium
Report
Form 4 Rapport Therapeutics, For: Dec 15 Filed by: Bredt David
12/1
04:18 pm
rapp
Form 4 Rapport Therapeutics, For: Nov 26 Filed by: Gault Cheryl
Medium
Report
Form 4 Rapport Therapeutics, For: Nov 26 Filed by: Gault Cheryl
11/18
04:28 pm
rapp
Form 4 Rapport Therapeutics, For: Nov 17 Filed by: Ceesay Abraham
Medium
Report
Form 4 Rapport Therapeutics, For: Nov 17 Filed by: Ceesay Abraham
11/18
04:25 pm
rapp
Form 4 Rapport Therapeutics, For: Nov 17 Filed by: Bredt David
Medium
Report
Form 4 Rapport Therapeutics, For: Nov 17 Filed by: Bredt David
11/14
01:09 pm
rapp
Form SCHEDULE 13G/A Rapport Therapeutics, Filed by: Cormorant Asset Management, LP
Low
Report
Form SCHEDULE 13G/A Rapport Therapeutics, Filed by: Cormorant Asset Management, LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: